Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    12583947 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels
Condition: Dyslipidemia
Intervention: Other: VASCAZEN
2 Completed Omacor and Placebo in Carotid Plaque Stability
Condition: Cardiovascular Disease
Intervention: Drug: Omega-3-acid ethyl ester 90 (n-3 PUFA)

Indicates status has not been verified in more than two years